Impact Therapeutics News and Activities

Acquisition, funding and merger involving Impact Therapeutics.

• Impact Therapeutics has just announced a $55 Million fundraising (posted on August 8 2025).

View the org chart displaying its 6 main executives

Most searched biographies at Impact Therapeutics

• Sui Xiong Cai, Chief Executive Officer
• Cong Xu, Chairman of the Board
• Susie Xu, Executive Vice President & Chief Financial Officer

Create your alert
to follow the executive moves at Impact Therapeutics.

Impact Therapeutics has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Impact Therapeutics

Social media about Impact Therapeutics

• Impact Therapeutics on Wikipedia, Google News & Yahoo Finance
• Impact Therapeutics on LinkedIn, X (Twitter) & YouTube